DQIRX
Price
$33.03
Change
+$0.24 (+0.73%)
Updated
Jul 3 closing price
Net Assets
1.75B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

DQIRX vs VIVAX

Header iconDQIRX vs VIVAX Comparison
Open Charts DQIRX vs VIVAXBanner chart's image
BNY Mellon Equity Income Fund I
Price$33.03
Change+$0.24 (+0.73%)
VolumeN/A
Net Assets1.75B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
DQIRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DQIRX vs. VIVAX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DQIRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. DQIRX (1.75B). VIVAX pays higher dividends than DQIRX: VIVAX (2.06) vs DQIRX (1.45). DQIRX was incepted earlier than VIVAX: DQIRX (19 years) vs VIVAX (33 years). DQIRX (0.80) is less costly to investors than VIVAX (0.17). DQIRX is a more actively managed with annual turnover of: 28.63 vs. VIVAX (9.00). DQIRX has a lower initial minimum investment than VIVAX: DQIRX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 11.40 vs. DQIRX (7.82). DQIRX return over 5 years is better than : 92.68 vs. VIVAX (79.11).
DQIRXVIVAXDQIRX / VIVAX
Total Expense Ratio0.780.17459%
Annual Report Gross Expense Ratio0.800.17471%
Fund Existence19 years33 years-
Gain YTD6.9015.603123%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.75B189B1%
Annual Yield % from dividends1.452.0670%
Returns for 1 year7.8211.4069%
Returns for 3 years46.4334.39135%
Returns for 5 years92.6879.11117%
Returns for 10 years112.32114.5198%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX48.891.03
+2.15%
MoonLake Immunotherapeutics
EVER24.530.34
+1.41%
EverQuote
LPTH3.050.01
+0.33%
LightPath Technologies
STX149.44-2.50
-1.65%
Seagate Technology Holdings PLC
KAPA0.65-0.04
-6.33%
Kairos Pharma Ltd.